Alissa Nauryzbayeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alissa Nauryzbayeva has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aigerim Abilova
“University Medical Center” Corporate Fund, Astana, Kazakhstan
1 shared publication - Aktoty Yestibayeva
Astana Medical University, Astana, Kazakhstan
1 shared publication - Alina Dospayeva
Astana Medical University, Astana, Kazakhstan
1 shared publication - Bagyzhan Syzdykova
Astana Medical University, Astana, Kazakhstan
1 shared publication - Bauyrzhan Kaliyev
NJSC «National Research Cardiac Surgery Center
1 shared publication - Dinara Alzhanova
Astana Medical University, Astana, Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 17 August 2026
- Published by Public Health Institute of Georgia in Georgian Medical Journal
- Vol. 1 (3)
A case of Baló concentric sclerosis: a fulminant variant of multiple sclerosis?
Modern research into Baló concentric sclerosis has revealed a characteristic neuroradiological picture, while clinical manifestations range widely, including benign and malignant forms of demyelinating disease. Immunological diagnostics remain poorly characterised. We report a 17-year-old Caucasian male from Kazakhstan who initially presented to the emergency department with acute focal neurological deficits, including right-sided hemiparesis and gait unsteadiness, mimicking acute ischaemic stroke. Brain magnetic resonance imaging revealed multifocal lesions in the thalamus, temporal, and parietal lobes with pronounced diffusion restriction, confirming Baló concentric sclerosis. Following high-dose intravenous methylprednisolone, rapid neurological improvement was observed. A subsequent relapse led to the diagnosis of relapsing-remitting multiple sclerosis, and disease-modifying therapy with ocrelizumab was initiated with a satisfactory response. This case demonstrates that Pattern I demyelination can underlie atypical variants evolving into classical multiple sclerosis, highlighting the need to combine neuroimaging with immunopathological profiling to predict disease trajectories. Keywords: Baló concentric sclerosis; multiple sclerosis; concentric ring lesions; demyelinating disease; ocrelizumab; corticosteroid treatment; case report
- 17 August 2026
- Published by Public Health Institute of Georgia in Georgian Medical Journal
- Vol. 1 (3)
Open AccessA case of Baló concentric sclerosis: a fulminant variant of multiple sclerosis?
Modern research into Baló concentric sclerosis has revealed a characteristic neuroradiological picture, while clinical manifestations range widely, including benign and malignant forms of demyelinating disease. Immunological diagnostics remain poorly characterised. We report a 17-year-old Caucasian male from Kazakhstan who initially presented to the emergency department with acute focal neurological deficits, including right-sided hemiparesis and gait unsteadiness, mimicking acute ischaemic stroke. Brain magnetic resonance imaging revealed multifocal lesions in the thalamus, temporal, and parietal lobes with pronounced diffusion restriction, confirming Baló concentric sclerosis. Following high-dose intravenous methylprednisolone, rapid neurological improvement was observed. A subsequent relapse led to the diagnosis of relapsing-remitting multiple sclerosis, and disease-modifying therapy with ocrelizumab was initiated with a satisfactory response. This case demonstrates that Pattern I demyelination can underlie atypical variants evolving into classical multiple sclerosis, highlighting the need to combine neuroimaging with immunopathological profiling to predict disease trajectories. Keywords: Baló concentric sclerosis; multiple sclerosis; concentric ring lesions; demyelinating disease; ocrelizumab; corticosteroid treatment; case report
- Open Access
- 12 January 2024
- Published by Wiley in Case Reports in Medicine
- Vol. 2024, 1-3
Delayed Diagnosis of Perrault Syndrome: A Rare Genetic Disorder
Perrault syndrome (PRLTS) is a rare autosomal recessive disorder which is associated with pathogenic variants in HSD17B4, HARS2, CLPP, LARS2, GGPS1, RMND1, TWNK, ERAL1, and PRORP genes. The disease is characterized by sensorineural hearing loss, sometimes with neurological signs, including progressive sensory and motor peripheral neuropathy, cerebellar ataxia, mild mental retardation, and ovarian dysgenesis in females. In this article, we report a case of a child diagnosed with spastic diplegic cerebral palsy. Determination of the segregation status of the parents of a proband with a rare compound heterozygote in the gene HSD17B4 will help the genetic counselling for the prognosis of Perrault syndrome in the family.
- 12 January 2024
- Published by Wiley in Case Reports in Medicine
- Vol. 2024, 1-3
Open AccessDelayed Diagnosis of Perrault Syndrome: A Rare Genetic Disorder
Perrault syndrome (PRLTS) is a rare autosomal recessive disorder which is associated with pathogenic variants in HSD17B4, HARS2, CLPP, LARS2, GGPS1, RMND1, TWNK, ERAL1, and PRORP genes. The disease is characterized by sensorineural hearing loss, sometimes with neurological signs, including progressive sensory and motor peripheral neuropathy, cerebellar ataxia, mild mental retardation, and ovarian dysgenesis in females. In this article, we report a case of a child diagnosed with spastic diplegic cerebral palsy. Determination of the segregation status of the parents of a proband with a rare compound heterozygote in the gene HSD17B4 will help the genetic counselling for the prognosis of Perrault syndrome in the family.